PALISADE BIO, INC. — Investor Relations & Filings
Filings indexed
1,045
across all filing types
Latest filing
2026-05-12
Regulatory Filings
Country
US
United States of America
Listing
US
PALI
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company that develops and advances novel therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases. The company focuses on next-generation precision therapies, utilizing its phosphodiesterase-4 (PDE4) inhibitor prodrug platform. This platform is engineered to enable the targeted, oral delivery of therapeutics specifically to the gastrointestinal tract, aiming to enhance efficacy at the disease site while minimizing systemic side effects. Its lead development candidate, PALI-2108, is an oral PDE4 inhibitor prodrug being investigated for the treatment of inflammatory bowel diseases like ulcerative colitis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | |
| 10-Q - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | |
| ARS - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-29 | English | |
| 8-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-02 | English | |
| 10-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-03-20 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 45341987 | S-3 - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | ||
| 45339305 | 10-Q - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | ||
| 38828586 | ARS - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-29 | English | ||
| 33156249 | 8-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-02 | English | ||
| 33002255 | 10-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-03-20 | English | ||
| 29064240 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29064235 | 4 Filing | 2026-02-13 | English | ||
| 29064230 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 29064204 | 4 Filing | 2026-02-13 | English | ||
| 29064219 | 4 Filing | 2026-02-11 | English | ||
| 29064206 | 4 Filing | 2026-02-11 | English | ||
| 29064260 | SCHEDULE 13G Filing | 2026-02-10 | English | ||
| 29064212 | 4 Filing | 2026-01-21 | English | ||
| 29064249 | 4 Filing | 2026-01-13 | English | ||
|
2025
1 filing
| |||||
| 11961042 | 8-K | 2025-12-04 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
PALISADE BIO, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35274/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35274 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35274 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35274 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35274}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PALISADE BIO, INC. (id: 35274)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.